Impart: Provider-Assisted HIV Partner Notification

Not Applicable

Completed

• Conditions: HIV Infections; Partner Communication
• Interventions: Behavioral: Standard Care; Behavioral: IMPART

• Registration Number: NCT04155320
• Lead Sponsor: University of Illinois at Chicago

Brief Summary

Researchers will conduct a 2-arm pilot randomized controlled trial with HIV-infected index patients recruited from two all-male prisons in Indonesia to assess the acceptability and feasibility of provider-assisted HIV partner notification (provider referral) and examine its potential to increase the number of partners who are tested for HIV and subsequently linked to prevention and treatment services.

Detailed Description

This study compares three options for partner notification:

* Option 1 (Self-tell): Participant is encouraged to disclose his HIV+ status to his partner(s) and given information about sites where his partner(s) can receive free HIV testing.

* Option 2 (Tell together): Participant discloses his HIV+ status to his partners with a counselor (project staff) present. Counselor refers the partner to HIV testing, including a study-affiliated HIV testing site.

* Option 3 (Provider referral): Project staff (nurse or peer educator) will notify the partner anonymously - without identifying the participant (index patient). Partners are offered immediate HIV testing in their home or at a study-affiliated HIV testing site.

Study Timeline

• Study First Submitted: 2019-11-05
• Study First Submitted QC: 2019-11-05
• Study First Posted: 2019-11-07
• Study Start: 2020-01-27
• Primary Completion: 2021-03-26
• Study Completion: 2021-11-12
• Status Verified: 2022-05
• Last Update Submitted: 2022-05-17
• Last Update Posted: 2022-05-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group A	Standard Care	Subjects are encouraged to disclose their HIV status to their partner(s) with or without a counselor present (Options 1 \& 2).
Group B	IMPART	Subjects may choose to notify their partners themselves, with or without a counselor present (Options 1 \& 2), or choose to have one or more partners notified anonymously by project staff (Option 3).

Primary Outcome Measures

Name	Time	Method
Diagnosed	6 weeks from index patient enrollment	Number of partners who are HIV diagnosed subsequent to testing
Notified	6 weeks from index patient enrollment	Number of partners who are notified of shared HIV exposure
Tested	6 weeks from index patient enrollment	Number of partners who receive HIV testing subsequent to notification

Secondary Outcome Measures

Name	Time	Method
Linked to Care	6 weeks from index patient enrollment	Number of partners who have been evaluated for treatment by a physician subsequent to diagnosis
Initiated ART	6 weeks from index patient enrollment	Number of partners who have initiated antiretroviral therapy (ART) subsequent to linkage to care

Trial Locations

Locations (1)

Rutan Cipinang; 🇮🇩 Jakarta Pusat, Jawa Barat, Indonesia